Metabolic Diseases and Risk of Head and Neck Cancer: A Cohort Study Analyzing Nationwide Population-Based Data.
diabetes
head and neck cancer
hypertension
metabolic syndrome
obesity
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
04 Jul 2022
04 Jul 2022
Historique:
received:
04
01
2022
revised:
17
02
2022
accepted:
23
02
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
The aim of the study was to investigate the association between metabolic diseases and the risk of head and neck cancer (HNC) using nationwide population-based big data. This retrospective cohort study was conducted using the Korean National Health Insurance Service health checkup database. A total of 4,575,818 participants aged >40 years who received a health checkup in 2008 were enrolled, and we studied the incidence of HNC until 2019. We analyzed the risk of HNC according to the presence of metabolic diseases, such as obesity, dyslipidemia, hypertension, and diabetes. Although metabolic syndrome itself was not associated with HNC, each component of metabolic syndrome was associated with HNC. Underweight and diabetes were risk factors for HNC (HR: 1.694). High total cholesterol and high low-density lipoprotein cholesterol levels were factors that decreased the risk (HR 0.910 and 0.839). When we analyzed men and women separately, low total cholesterol level, low low-density lipoprotein cholesterol level, and hypertension were risk factors only in men. In addition, pre-obesity, obesity, and central obesity decreased the risk only in men. Each metabolic disease affects HNC in different ways. Underweight and diabetes increased the risk of HNC, whereas high total cholesterol and high low-density lipoprotein cholesterol levels decreased the risk of HNC.
Identifiants
pubmed: 35805048
pii: cancers14133277
doi: 10.3390/cancers14133277
pmc: PMC9265067
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Research Foundation of Korea
ID : No. 2020R1A5A2019413
Organisme : Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Republic of Korea
ID : HI20C1205
Références
Int J Epidemiol. 2017 Apr 1;46(2):e15
pubmed: 26822938
Cancer Metab. 2021 Jun 3;9(1):25
pubmed: 34082811
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2422-9
pubmed: 25172872
Nat Rev Cancer. 2004 Aug;4(8):579-91
pubmed: 15286738
Int J Cancer. 2006 Jul 1;119(1):236-8
pubmed: 16450399
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Obes Res. 2005 Aug;13(8):1466-75
pubmed: 16129730
Wien Klin Wochenschr. 2014 Mar;126(5-6):169-75
pubmed: 24615676
J Natl Cancer Inst. 2008 Jan 16;100(2):134-9
pubmed: 18182618
Lancet. 2005 Apr 16-22;365(9468):1398-405
pubmed: 15836888
JAMA. 2002 Oct 9;288(14):1723-7
pubmed: 12365955
Int J Cancer. 2013 Jun 15;132(12):2738-47
pubmed: 23175176
Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):497-503
pubmed: 22219317
J Hum Hypertens. 2005 May;19(5):373-9
pubmed: 15703772
Epidemiology. 2011 Nov;22(6):797-804
pubmed: 21881515
J Biol Chem. 2001 Sep 14;276(37):34480-5
pubmed: 11432865
Ear Nose Throat J. 2021 Feb;100(2):NP62-NP68
pubmed: 31170822
Diabet Med. 1999 May;16(5):442-3
pubmed: 10342346
Life Sci. 2019 Sep 15;233:116687
pubmed: 31348948
Diabetes Care. 2012 Nov;35(11):2402-11
pubmed: 23093685
Int J Epidemiol. 2010 Aug;39(4):1091-102
pubmed: 20123951
Mayo Clin Proc. 2008 Apr;83(4):489-501
pubmed: 18380996
Surg Oncol Clin N Am. 2015 Jul;24(3):379-96
pubmed: 25979389
Oncogene. 2010 May 6;29(18):2712-23
pubmed: 20190811
Oral Oncol. 2018 Aug;83:11-17
pubmed: 30098765
Diabetes Res Clin Pract. 2018 Sep;143:389-397
pubmed: 29807099
Endocr Pract. 2003 May-Jun;9(3):237-52
pubmed: 12924350
Auris Nasus Larynx. 2022 Feb;49(1):117-125
pubmed: 34092436
Cancer Epidemiol. 2019 Jun;60:208-215
pubmed: 31071526
Sci Rep. 2017 Mar 20;7:44877
pubmed: 28317900
Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):582-5
pubmed: 16537720
Thromb Haemost. 2001 Apr;85(4):730-5
pubmed: 11341512
Head Neck. 2013 Jul;35(7):914-22
pubmed: 22711227
Int J Obes (Lond). 2005 Feb;29(2):236-43
pubmed: 15505632
Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1646-50
pubmed: 15466982
Metabolism. 2015 Feb;64(2):182-9
pubmed: 25456095
Curr Opin Pharmacol. 2012 Dec;12(6):751-9
pubmed: 22824430
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Int J Epidemiol. 2015 Apr;44(2):673-81
pubmed: 26050257
Hypertension. 2012 Apr;59(4):802-10
pubmed: 22353615
Cancer Epidemiol. 2013 Aug;37(4):428-33
pubmed: 23562170
JAMA Otolaryngol Head Neck Surg. 2014 Aug;140(8):746-53
pubmed: 25058016
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):2038-2047
pubmed: 32763912
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):147-52
pubmed: 15716792
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
J Clin Lipidol. 2017 Jul - Aug;11(4):1073-1081
pubmed: 28669687
Clin Gastroenterol Hepatol. 2007 Feb;5(2):221-9; quiz 141
pubmed: 16931168
Am J Epidemiol. 2006 Oct 15;164(8):769-74
pubmed: 16952929
CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21
pubmed: 20554718